Related Experiment Videos
Human serum albumin versus serum: a comparative study on embryo transfer medium
I Khan1, C Staessen, P Devroey
1Center for Reproductive Medicine, Vrije Universiteit Brussel, Belgium.
Fertility and Sterility
|July 1, 1991
Summary
Human albumin (HSA) effectively replaces serum in embryo transfer media, demonstrating safety and suitability. This finding supports its use in assisted reproductive technologies for improved outcomes.
Area of Science:
- Reproductive Medicine
- In Vitro Fertilization
- Embryo Transfer Technology
Background:
- Serum has been traditionally used in embryo transfer (ET) media.
- Human serum albumin (HSA) has shown promise in embryo culture medium.
- Simplifying ET procedures is crucial for clinical application.
Purpose of the Study:
- To evaluate the efficacy of human albumin as a substitute for serum in embryo transfer medium.
- To compare pregnancy rates using different concentrations of serum and HSA in ET medium.
Main Methods:
- A prospective, randomized study involving 224 embryo transfer cycles.
- Patients were divided into three groups: 75% serum, 8% serum, and 2.25% human serum albumin (HSA).
- All procedures were conducted within an in vitro fertilization program for patients with at least one good-quality embryo.
Main Results:
- Overall pregnancy rates were 43% (75% serum), 27% (8% serum), and 36% (2.25% HSA).
- No statistically significant difference in pregnancy rates was observed between the three transfer media groups.
- Human serum albumin proved to be a safe and effective component in ET medium.
Conclusions:
- Human serum albumin (HSA) is a safe and suitable alternative to serum for embryo transfer medium.
- The study supports the use of HSA in both embryo culture and transfer procedures.
- This finding can lead to simplified protocols in assisted reproductive technology.